Isradipine is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Glenmark Pharmaceuticals Inc.,usa. The primary component is Isradipine.
Product ID | 68462-807_02ffa6f4-81c6-45c5-a9fd-a4353ab974ec |
NDC | 68462-807 |
Product Type | Human Prescription Drug |
Proprietary Name | Isradipine |
Generic Name | Isradipine |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2014-05-15 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA077169 |
Labeler Name | Glenmark Pharmaceuticals Inc.,USA |
Substance Name | ISRADIPINE |
Active Ingredient Strength | 3 mg/1 |
Pharm Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2018-08-31 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA077169 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-08-31 |
Marketing Category | ANDA |
Application Number | ANDA077169 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-08-31 |
Ingredient | Strength |
---|---|
ISRADIPINE | 2.5 mg/1 |
SPL SET ID: | f880f4cb-b41f-4277-9944-866d8de0717f |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
16252-539 | Isradipine | Isradipine |
16252-540 | Isradipine | Isradipine |
42806-263 | Isradipine | Isradipine |
42806-264 | Isradipine | Isradipine |
50268-454 | Isradipine | Isradipine |
50268-455 | Isradipine | Isradipine |
60429-385 | Isradipine | Isradipine |
60429-386 | Isradipine | Isradipine |
64850-910 | Isradipine | Isradipine |
64850-911 | Isradipine | Isradipine |
68151-1333 | Isradipine | Isradipine |
68462-807 | Isradipine | Isradipine |
68462-808 | Isradipine | Isradipine |